Urinary mRNA biomarker panel for the detection of urothelial carcinoma.

A microRNA biomarker panel for the non-invasive detection of bladder cancer. Oncotarget (2016) 0.82

Liquid biopsies for surveillance and monitoring treatment response of bladder cancer. Ann Transl Med (2016) 0.76

Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy. Oncotarget (2017) 0.75

Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine. J Cancer Res Clin Oncol (2017) 0.75

Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst (2008) 6.79

Bladder cancer. Lancet (2009) 4.43

Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res (2010) 2.23

Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clin Cancer Res (2007) 1.68

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess (2010) 1.62

Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 1.50

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. Eur Urol (2012) 1.49

Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia. Cancer Epidemiol Biomarkers Prev (2009) 1.37

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol (2002) 1.30

A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria. J Urol (2012) 1.15

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol (2010) 1.12

Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res (2008) 1.11

A candidate molecular biomarker panel for the detection of bladder cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.10

How important is urinary cytology in the diagnosis of urological malignancies? Eur Urol (2003) 1.06

Multiplex protein signature for the detection of bladder cancer in voided urine samples. J Urol (2013) 1.01

On non-detects in qPCR data. Bioinformatics (2014) 1.01

Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer? Clin Chem Lab Med (2003) 0.97

Quantitative analysis of miRNA expression in epithelial cells and tissues. Methods Mol Biol (2012) 0.88

Quality assurance of RNA expression profiling in clinical laboratories. J Mol Diagn (2011) 0.87

Natural interpretations in Tobit regression models using marginal estimation methods. Stat Methods Med Res (2015) 0.83

Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent. J Urol (1999) 0.82

Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. J Urol (2013) 0.81

A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma. BMC Urol (2015) 0.81

Improved Confidence Intervals for the Youden Index. PLoS One (2015) 0.80

Correlation of office-based cystoscopy and cytology with histologic diagnosis: how good is the reference standard? Urology (2005) 0.79

CXCL1 is elevated in the urine of bladder cancer patients. Springerplus (2015) 0.78

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol (2013) 0.95

A microRNA biomarker panel for the non-invasive detection of bladder cancer. Oncotarget (2016) 0.82

Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2. Oncotarget (2016) 0.76